N-(Phenoxyalkyl)amides as MT1 and MT2 ligands: Antioxidant properties and inhibition of Ca2+/CaM-dependent kinase II

被引:33
作者
Carocci, Alessia [1 ]
Catalano, Alessia [1 ]
Bruno, Claudio [1 ]
Lovece, Angelo [1 ]
Roselli, Maria Grazia [1 ]
Cavalluzzi, Maria Maddalena [1 ]
De Santis, Francesco [2 ]
De Palma, Annalisa [2 ]
Rusciano, Maria Rosaria [3 ]
Illario, Maddalena [3 ]
Franchini, Carlo [1 ]
Lentini, Giovanni [1 ]
机构
[1] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, I-70125 Bari, Italy
[2] Univ Bari Aldo Moro, Dipartimento Biosci Biotecnol & Biofarmaceut, I-70125 Bari, Italy
[3] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy
关键词
Antioxidants; Melatonin; CaMKII; DCFH-DA; DEPENDENT PROTEIN-KINASE; MELATONIN RECEPTORS; EXOGENOUS MELATONIN; PINEAL-GLAND; DYSFUNCTION; ENZYMES; SYSTEM; INVOLVEMENT; AGONISTS; THERAPY;
D O I
10.1016/j.bmc.2012.12.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently a series of chiral N-(phenoxyalkyl)amides have been reported as potent MT1 and MT2 melatonergic ligands. Some of these compounds were selected and tested for their antioxidant properties by measuring their reducing effect against oxidation of 2',7'-dichlorodihydrofluorescein (DCFH) in the DCFH-diacetate (DCFH-DA) assay. Among the tested compounds, N-[2-(3-methoxyphenoxy)propyl]butanamide displayed potent antioxidant activity that was stereoselective, the (R)-enantiomer performing as the eutomer. This compound displayed strong cytoprotective activity against H2O2-induced cytotoxicity resulting slightly more active than melatonin, and performed as Ca2+/calmodulin-dependent kinase II (CaMKII) inhibitor, too. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:847 / 851
页数:5
相关论文
共 46 条
[1]   Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias [J].
Anderson, ME .
PHARMACOLOGY & THERAPEUTICS, 2005, 106 (01) :39-55
[2]  
Barrenetxe J, 2004, J PHYSIOL BIOCHEM, V60, P61, DOI 10.1007/BF03168221
[3]   In vitro inhibition of Ca2+/calmodulin-dependent kinase II activity by melatonin [J].
BenitezKing, G ;
Rios, A ;
Martinez, A ;
AntonTay, F .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1996, 1290 (02) :191-196
[4]   CHARACTERIZATION OF THE CELLULAR REDUCTION OF 3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE (MTT) - SUBCELLULAR-LOCALIZATION, SUBSTRATE DEPENDENCE, AND INVOLVEMENT OF MITOCHONDRIAL ELECTRON-TRANSPORT IN MTT REDUCTION [J].
BERRIDGE, MV ;
TAN, AS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 303 (02) :474-482
[5]  
Blask David E., 2002, Current Topics in Medicinal Chemistry, V2, P113, DOI 10.2174/1568026023394407
[6]   ANTIOXIDANT DETERMINATIONS BY THE USE OF A STABLE FREE RADICAL [J].
BLOIS, MS .
NATURE, 1958, 181 (4617) :1199-1200
[7]   Design, synthesis, and pharmacological effects of structurally simple ligands for MT1 and MT2 melatonin receptors [J].
Carocci, Alessia ;
Catalano, Alessia ;
Lovece, Angelo ;
Lentini, Giovanni ;
Duranti, Andrea ;
Lucini, Valeria ;
Pannacci, Marilou ;
Scaglione, Francesco ;
Franchini, Carlo .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) :6496-6511
[8]  
Carrillo-Vico A, 2006, CURR OPIN INVEST DR, V7, P423
[9]   Synthesis and Toxicopharmacological Evaluation of m-Hydroxymexiletine, the First Metabolite of Mexiletine More Potent Than the Parent Compound on Voltage-Gated Sodium Channels [J].
Catalano, Alessia ;
Desaphy, Jean-Francois ;
Lentini, Giovanni ;
Carocci, Alessia ;
Di Mola, Antonia ;
Bruno, Claudio ;
Carbonara, Roberta ;
De Palma, Annalisa ;
Budriesi, Roberta ;
Ghelardini, Carla ;
Perrone, Maria Grazia ;
Colabufo, Nicola Antonio ;
Camerino, Diana Conte ;
Franchini, Carlo .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (03) :1418-1422
[10]   Characterization of substrate phosphorylation and use of calmodulin mutants to address implications from the enzyme crystal structure of calmodulin-dependent protein kinase I [J].
Chin, D ;
Winkler, KE ;
Means, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (50) :31235-31240